Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase
Authors:
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (3) , 675-678
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESYBioorganic & Medicinal Chemistry Letters, 2004
- Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acidBioorganic & Medicinal Chemistry Letters, 2004
- HCV NS5b RNA-Dependent RNA Polymerase Inhibitors: From α,γ-Diketoacids to 4,5-Dihydroxypyrimidine- or 3-Methyl-5- hydroxypyrimidinonecarboxylic Acids. Design and SynthesisJournal of Medicinal Chemistry, 2004
- Binding Mode Determination of Benzimidazole Inhibitors of the Hepatitis C Virus RNA Polymerase by a Structure and Dynamics StrategyAngewandte Chemie International Edition, 2004
- Treatment of chronic hepatitis C: A systematic reviewHepatology, 2002
- Optimal therapy of hepatitis CHepatology, 2002
- Hepatitis C: an epidemiological reviewJournal of Viral Hepatitis, 2002
- Treatment of chronic hepatitis C with PEGylated interferon and ribavirinCurrent Gastroenterology Reports, 2002
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- Emerging therapies for hepatitis C virus infectionExpert Opinion on Emerging Drugs, 2001